[1]
C. . Wang, H. . Lin, W. . Zhao, Y. . Liang, Y. . Chen, and C. Wang, “MiR-26a-5p exerts its influence by targeting EP300, a molecule known for its role in activating the PI3K/AKT/mTOR signaling pathway in CD8+tumor-infiltrating lymphocytes of colorectal cancer: miR-26a-5p targets EP300 in colorectal cancer lymphocytes”, Cell Mol Biol (Noisy-le-grand), vol. 69, no. 12, pp. 232–241, Nov. 2023.